- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Paediatric growth hormone deficiency
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 436KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 70KB)
Somatrogon – March 2022
Somatrogon: Injection 24 mg in 1.2 mL pre-filled single-use pen, Injection 60 mg in 1.2 mL pre-filled single-use pen; Ngenla®
Last updated
7 July 2022